Evaluating the Effect of Aliskiren Versus HCTZ on Coronary Flow Reserve in Hypertensive Type II Diabetics
Stopped Due to safety concerns re: the concomitant use of aliskiren with an ACEi or ARB.
Conditions
- Hypertension
- Diabetes Type 2
Interventions
- DRUG: Aliskiren
- DRUG: Hydrochlorothiazide
Sponsor
Corewell Health East
Collaborators